Mucosal Cytokine Production in Small-Intestinal Bacterial Overgrowth

References

• Mosmann T R, Moore K W. The role of IL‐10 in cross regulation of TH1 and TH2 responses. Immunol Today 1991; 12: 49–53
   PubMedGoogle Scholar
• Elson C O. Interleukin‐10 and counting. Gasrroenterology 1991; 100: 1776–81
   PubMedGoogle Scholar
• Romagnani S. Human TH1 and TH2 subsets: regulation of differentiation and role in protection and immunopathology. Int Arch Allergy Immunol 1992; 98: 279–85
   PubMed Web of Science ®Google Scholar
• Targan S R. The lamina propria: a dynamic, complex mucosal compartment. Neuro-immuno-physiology of the gastro-intestinal mucosa, R H Stead, M H Perdue, H Cooke, D W Powell, K E Barrett. Ann NY Acad Sci. 1992; 664: 61–8
   Google Scholar
• Gordon J R, Burd P R, Galli S J. Mast cells as a source of multifunctional cytokines. Immunol Today 1990; 11: 458–64
   PubMedGoogle Scholar
• Kohase M, Henriksen‐de Stefano D, May L T, Vilcek J, Sehgal P B. Induction of β2‐interferon by tumour necrosis factor: a homeostatic mechanism in the control of cell proliferation. Cell 1986; 45: 659–66
   PubMed Web of Science ®Google Scholar
• Jirik F R, Podor T J, Hirano T, Kishimoto T, Loskutoff D J, Carson D A, et al. Bacterial lipopolysaccharide and inflammatory mediaors augment IL‐6 secretion by human endothelial cells. J Immunol 1989; 142: 144–7
   PubMed Web of Science ®Google Scholar
• Shirota K, Le Duy L, Yuan S Y, Jothy S. Interleukin‐6 and its receptor are expressed in human intestinal epithelial cells. Virchows Arch [Cell Pathol] 1990; 58: 303–8
   Google Scholar
• Brandtzaeg P, Halstensen T S, Kett K, Krajci P, Kvale D, Rognum T O, et al. Immunobiology and immunopathology of human gut mucosa: humoral immunity and intrapepithelial lymphocytes. Gastroenterology 1989; 97: 1562–84
   PubMed Web of Science ®Google Scholar
• Nilsen E M, Lundin K EA, Krajci P, Scott H, Sollid L M, Brandtzaeg P. Gluten specific, HLA‐DQ restricted T cells from coeliac mucosa produce cytokines with Thl or Th0 profile dominated by interferon γ. Gut 1995; 37: 766–76
   PubMed Web of Science ®Google Scholar
• Mitsuyama K, Sasaki E, Toyonaga A, Ikeda H, Tsuruta O, Irie A, et al. Colonic mucosal interleukin‐6 in inflammatory bowel disease. Digestion 1991; 50: 104–11
   PubMed Web of Science ®Google Scholar
• Mitsuyama K, Sata M, Tanikawa K. Significance of interleukin‐6 in patients with inflammatory bowel disease. Gastroenterol Jpn 1991; 26: 20–8
   PubMedGoogle Scholar
• Casellas F, Papo M, Guarner F, Antolin M, Armengol J R. Reduction of intracolonic release of tumor necrosis factor as an objective marker of remission in chronic ulcerative colitis. Gastroenterology 1993; 104: A677
   Web of Science ®Google Scholar
• Plevy S E, Targan S R, Andus T, Toyoda H. Differentiation of Crohn's disease from ulcerative colitis mucosal inflammation by levels of TNF‐α mRNA. Gastroenterology 1993; 104: A764
   Web of Science ®Google Scholar
• Breese E, Braegger C P, Corrigan C J, Walker‐Smith J A, MacDonald T T. Interleukin‐2 and interferon‐secreting T cells in normal and diseased human intestinal mucosa. Immunology 1993; 78: 127–31
   PubMed Web of Science ®Google Scholar
• Simon G L, Gorbach S L. The human intestinal microflora. Dig Dis Sci 1986; 31: 147–62, Suppl
   PubMed Web of Science ®Google Scholar
• Khoo U Y, Macpherson A JS, Philpott‐Howard J, Forgacs I, Bjarnason I. The mucosal immunoglobulin response to bacterial antigens in inflammatory bowel disease. Gastroenterology 1993; 104: A724
   PubMed Web of Science ®Google Scholar
• Aderka D, Le J, Vilcek J. IL‐6 inhibits lipopolysaccharide‐induced tumour necrosis factor production in cultured human monocytes, U937 cells, and in mice. J Immunol 1989; 143: 3517–23
   PubMed Web of Science ®Google Scholar
• Crago S S, Kutteh W H, Moro I, Allansmith M R, Radl J, Haajiman J J, et al. Distribution of IgA1, IgA2 and J‐chain containing cells in human tissues. J Immunol 1984; 132: 16–8
   PubMed Web of Science ®Google Scholar
• Barton J R, Riad M, Gaze M N, Maran A GD, Ferguson A. Mucosal immunodeficiency in smokers and in patients with epithelial head and neck tumours. Gut 1990; 31: 378–82
   PubMed Web of Science ®Google Scholar
• Alverdi J, Aoys E. The effect of glucocorticoid administration on bacterial translocation. Ann Surg 1991; 214: 719–23
   PubMed Web of Science ®Google Scholar
• Cozon G, Cannella D, Perriat‐Langevin A, Jeannin M, Trublereau P, Ecochard R, et al. Transient secretory IgA deficiency in mice after cyclophosphamide treatment. Clin Immunol Immunopathol 1991; 61: 93–102
   PubMedGoogle Scholar
• Stern M, Dietrich R, Muller J. Small intestinal mucosa in coeliac disease and cow's milk protein intolerance. Eur J Pediatr 1982; 139: 101–5
   PubMed Web of Science ®Google Scholar
• Budhraja M, Levendoglu H, Kocka F, Mangkornkanok M, Sherer R. Duodenal mucosal T cell subpopulation and bacterial cultures in acquired immune deficiency syndrome. Am J Gastroenterol 1987; 82: 427–31
   PubMed Web of Science ®Google Scholar
• Wood G M, Gearty J C, Cooper B T. Small bowel morphology in British Indian and Afro‐Caribbean subjects: evidence of tropical enteropathy. Gut 1991; 32: 256–9
   PubMed Web of Science ®Google Scholar
• Bjarnason I, Zanelli G, Smith T, Prouse P, Williams P, Smethurst P, et al. Non‐steroidal anti‐inflammatory druginduced intestinal inflammation in humans. Gastroenterology 1987; 93: 480–9
   PubMed Web of Science ®Google Scholar
• Kirsch G. Bacterial overgrowth. Am J Gastroenterol 1990; 85: 231–7
   PubMed Web of Science ®Google Scholar
• Drude R B, Hines C. The pathophysiology of intestinal bacterial overgrowth syndromes. Ann Intern Med 1980; 140: 1349–52
   Google Scholar
• Haboubi N Y, Montgomery R D. Small‐bowel bacterial overgrowth in elderly people: clinical significance and response to treatment. Age Ageing 1992; 21: 13–9
   PubMed Web of Science ®Google Scholar
• Riordan S M, McIver C J, Bolin T D, Duncombe V M. Fasting breath hydrogen concentrations in gastric and small intestinal bacterial overgrowth. Scand J Gastroenterol 1995; 30: 252–7
   PubMed Web of Science ®Google Scholar
• Morson B C, Dawson I MP, Day D W, Jass J R, Price A B, Williams G T. Gastrointestinal pathology3rd ed. Blackwell Scientific Publications, Oxford 1990
   Google Scholar
• Valdovinos M A, Camilleri M, Thamforde G M, Frie C. Reduced accuracy of 14C‐D‐xylose breath test for detecting bacterial overgrowth in gastrointestinal motility disorders. Scand J Gastroenterol 1993; 28: 963–8
   PubMed Web of Science ®Google Scholar
• Kishimoto T. The biology of interleukin 6. Blood 1989; 74: 1–10
   PubMed Web of Science ®Google Scholar
• Saltzman J R, Kowdley K V, Pedrosa M C, Sepe T, Golner B, Perrone G, et al. Bacterial overgrowth without clinical malabsorption in elderly hypochlorhydric subjects. Gastroenterology 1994; 106: 615–23
   PubMed Web of Science ®Google Scholar
• Klimpel G R, Asuncion M, Haithcoat J, Niesel D W. Cholera toxin and Salmonella typhimurium induce different cytokine profiles in the gastrointestinal tract. Infect Immun 1995; 63: 1134–7
   PubMed Web of Science ®Google Scholar
• Arnold J W, Klimpel G R, Niesel D W. Tumor necrosis factor (TNFα) regulates intestinal mucus production during salmonellosis. Cell Immunol 1993; 151: 336–44
   PubMed Web of Science ®Google Scholar
• Arnold J W, Niesel D W, Anable C R, Hess C B, Asuncion M, Cho Y J, et al. Tumor necrosis factor α mediates the early pathology in Salmonella infection of the gastrointestinal tract. Microb Pathog 1993; 14: 217–27
   PubMed Web of Science ®Google Scholar
• Farmer J J, III, Kelly M T. Enterobacteriaceae. Manual of clinical microbiology5th ed., A Balows. American Society for Microbiology, Washington, DC 1991, editor‐in‐chief
   Google Scholar
• Sommers H M. The indigenous microbiota of the human host. The biologic and clinical basis of infectious diseases2nd ed., G P Youmans, P Y Paterson, H M Sommers. WB Saunders Co, Philadelphia 1980; 83–94
   Google Scholar